AstraZeneca Pharma falls on profit-taking

Reuters | Updated on: Dec 06, 2021

Shares of AstraZeneca Pharma India Ltd today fell as much as 5.7 per cent, after gaining 26.7 per cent in the last three sessions till Thursday.

Investors’ outpoint gains were due to increasing focus of the parent in listed unit vs 100 per cent unlisted subsidiary.

Recent launches and distribution deals have happened via AstraZeneca’s listed unit only.

AstraZeneca had launched a drug diabetes treatment on Thursday. The company has entered into a distribution deal with Sun Pharmaceutical Industries and Dr. Reddy’s Labs.

Published on June 12, 2015
This article is closed for comments.
Please Email the Editor

You May Also Like

Recommended for you